Acanthamoeba Keratitis (AK), also known as Acanthamoeba eye infection, is a serious parasitic corneal infection. This page provides information on AK diagnosis, clinical documentation, and medical coding for healthcare professionals. Learn about signs, symptoms, treatment, and ICD-10 codes related to Acanthamoeba Keratitis for accurate medical records and billing.
Also known as
Certain infectious and parasitic diseases
Covers various infectious and parasitic eye diseases, including Acanthamoeba keratitis.
Disorders of eyelid, lacrimal system, and orbit
Includes inflammatory conditions of the eye and adnexa potentially related to Acanthamoeba infection.
Keratitis
Specifically encompasses various forms of corneal inflammation, including that caused by Acanthamoeba.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the diagnosis Acanthamoeba Keratitis confirmed?
When to use each related code
| Description |
|---|
| Rare but serious eye infection. |
| Corneal inflammation, often from bacteria or viruses. |
| Fungal eye infection, can be severe. |
AK symptoms mimic conjunctivitis, leading to incorrect coding with less specific ICD-10 codes like H10, impacting reimbursement and quality metrics.
Failing to specify laterality (right, left, bilateral) with ICD-10 codes (e.g., H19.011, H19.012, H19.013) for AK can lead to claim denials.
Insufficient documentation of AK diagnosis, including causative organism and severity, hinders accurate coding and compliance audits, affecting CDI efforts.
Q: What are the most effective diagnostic techniques for differentiating Acanthamoeba Keratitis (AK) from other corneal infections like fungal keratitis or Herpes Simplex Keratitis?
A: Differentiating Acanthamoeba Keratitis (AK) from other corneal infections requires a multifaceted approach. While clinical presentation can offer initial clues, definitive diagnosis relies on laboratory confirmation. Confocal microscopy, demonstrating characteristic double-walled cysts or trophozoites within the cornea, is highly specific for AK. Corneal scraping for culture on non-nutrient agar with *E. coli* overlay is the gold standard for diagnosis, but it can take several days to yield results. PCR-based assays offer faster and more sensitive detection of Acanthamoeba DNA. Consider implementing PCR testing in cases with high clinical suspicion of AK where confocal microscopy is unavailable. In challenging cases, comparing clinical features, including ring infiltrates, perineural infiltrates, and radial keratoneuritis, alongside laboratory results, aids in distinguishing AK from fungal keratitis or Herpes Simplex Keratitis. Explore how combining diagnostic modalities improves accuracy and speeds up treatment initiation for AK.
Q: How should I manage Acanthamoeba Keratitis (AK) pain in patients, given its often severe and debilitating nature?
A: Managing Acanthamoeba Keratitis (AK) pain effectively requires addressing both the underlying infection and the associated inflammation and neuropathic pain. Topical anti-inflammatory agents, such as corticosteroids, may be used judiciously under close monitoring as they can exacerbate the infection in some cases. Systemic analgesics, including NSAIDs and opioids, can be prescribed for moderate to severe pain relief. For debilitating neuropathic pain, consider implementing topical or oral agents such as gabapentin or pregabalin. Adjunctive therapies like topical cycloplegics can help relieve ciliary spasm and photophobia. Furthermore, addressing any underlying dry eye associated with AK through lubricating eye drops can improve patient comfort. Learn more about pain management strategies in AK to ensure optimal patient outcomes.
Patient presents with complaints consistent with Acanthamoeba keratitis (AK), also known as Acanthamoeba eye infection. Symptoms include severe eye pain, photophobia, foreign body sensation, excessive tearing, and blurred vision. On examination, the patient exhibits corneal edema, stromal infiltrates, and a characteristic ring-shaped infiltrate in the cornea. Slit-lamp examination reveals corneal neovascularization and in some cases, a hypopyon. The patient reports a history of contact lens use, specifically mentioning overnight wear and inadequate lens hygiene practices, a known risk factor for Acanthamoeba keratitis. Differential diagnosis includes fungal keratitis, herpetic keratitis, and bacterial keratitis. Diagnosis of Acanthamoeba keratitis is confirmed via corneal scraping and confocal microscopy demonstrating the presence of Acanthamoeba trophozoites or cysts. Treatment plan includes topical application of biguanide disinfectants such as polyhexamethylene biguanide (PHMB) and chlorhexidine, often in combination with a diamidine like propamidine isethionate. Patient education regarding contact lens hygiene, including proper cleaning, disinfection, and storage, is crucial. Follow-up appointments are scheduled for close monitoring of treatment response and to assess for potential complications such as corneal scarring and permanent vision loss. ICD-10 code B00.2 will be used for billing purposes. The prognosis is guarded, with potential for significant visual impairment if treatment is delayed or inadequate. The patient is advised to discontinue contact lens wear until the infection is resolved and re-evaluated for contact lens wear suitability at a later date.